Skip to main content
Back
Watch Compare

Zomedica Corp.

Data quality: 100%
ZOMDF
OTC Manufacturing Chemicals
$0.11
▼ $0.01 (-4.27%)
Mkt Cap: 109.26 M
Price
$0.11
Mkt Cap
109.26 M
Day Range
$0.11 — $0.12
52-Week Range
$0.04 — $0.16
Volume
149,330
Open $0.11
50D / 200D Avg
$0.13
12.09% below
50D / 200D Avg
$0.09
25.98% above

Quick Summary

Key Takeaways

Negative free cash flow of -18.22 M
Capital efficient — spends only 1.77% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)17.39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-66.81%
Below sector avg (-53.41%)
ROIC-53.14%
Net Margin-255.57%
Op. Margin-263.36%

Safety

Debt / Equity
N/A
Current Ratio7.67
Interest CoverageN/A

Valuation

PE (TTM)
-1.33
Above sector avg (-1.48)
P/B Ratio0.91
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.3 -1.5
P/B 0.9 1.6
ROE % -66.8 -53.4
Net Margin % -255.6 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17.39% Revenue Growth (3Y) 12.77%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 32.03 M Net Income (TTM) -81.86 M
ROE -66.81% ROA -61.23%
Gross Margin 67.68% Operating Margin -263.36%
Net Margin -255.57% Free Cash Flow (TTM) -18.22 M
ROIC -53.14% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.67
Interest Coverage N/A Asset Turnover 0.24
Working Capital 56.26 M Tangible Book Value 79.59 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.33 Forward P/E N/A
P/B Ratio 0.91 P/S Ratio 3.41
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.67%
Market Cap 109.26 M Enterprise Value 101.77 M
Per Share
EPS (Diluted TTM) -0.08 Revenue / Share 0.03
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.77% FCF Conversion 22.25%
SBC-Adj. FCF -20.43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 32.03 M 27.29 M 25.19 M 4.13 M —
Net Income -81.86 M -46.98 M -34.53 M -17.02 M -16.91 M
EPS (Diluted) -0.08 -0.05 -0.04 — —
Gross Profit 21.68 M 19.09 M 17.32 M 13.65 M —
Operating Income -84.35 M -51.05 M -31.59 M -21.92 M -16.76 M
EBITDA — — — — —
R&D Expenses 7.17 M 7.27 M 5.74 M 2.58 M 8.04 M
SG&A Expenses — — — 33.00 M —
D&A — — — — 305,914.0
Interest Expense — 175,000.0 175,000.0 1,000.0 732.0
Income Tax -278,000.0 -557,000.0 -1.33 M -2.37 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 127.04 M 207.36 M 253.20 M 279.61 M 66.14 M
Total Liabilities 11.64 M 11.70 M 13.18 M 12.22 M 3.12 M
Shareholders' Equity 115.40 M 195.66 M 240.02 M 267.39 M 51.07 M
Total Debt — — — — 527,360.0
Cash & Equivalents 9.02 M 7.02 M 12.95 M 27.40 M 61.99 M
Current Assets 64.04 M 81.77 M 99.88 M 123.50 M 62.87 M
Current Liabilities 9.45 M 9.33 M 9.03 M 7.81 M 2.03 M